Artificial intelligence yields new antibiotic
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.
Findings could help researchers design drugs to treat influenza B infections.
Neuroscientists identify genes that modulate the disease’s toxic effects.
Study suggests noninvasive spectroscopy could be used to monitor blood glucose levels.
New light-sensitive material could eliminate some of the endoscopic procedures needed to remove gastrointestinal devices.
Study shows no effect from program intended to reduce repeated hospitalizations by targeting high-cost patients.
Even when people believed Hillary Clinton would win the 2016 election, they did not use “she” to refer to the next president.
Using specialized liver cells, a new test can quickly detect potentially cancer-causing DNA damage.
Economists analyze how patients and health care providers value Medicaid.
Biologists uncover an evolutionary trick to control gene expression that reverses the flow of genetic information from RNA splicing back to transcription.
Muscle relaxants delivered to the ureter can reduce contractions that cause pain when passing a stone.
Team of researchers including MIT Professor Angela Koehler obtains $5.8 million grant to study fusion-positive alveolar rhabdomyosarcoma.
Researchers develop a method to isolate and sequence the RNA of T cells that react to a specific target.
Coating particles with “right-handed” molecules could help them penetrate cancer cells more easily.
Materials could be useful for delivering drugs or imaging agents in the body; may offer alternative to some industrial plastics.